Status:
NOT_YET_RECRUITING
A Pilot Study Evaluating the Potential of 18F Fluorodeoxyglucose PET-CT Imaging in Diagnosing Cardiac Rejection.
Lead Sponsor:
Royal Brompton & Harefield NHS Foundation Trust
Conditions:
Cardiac Transplant Rejection
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
This pilot study aims to assess whether 18F-FDG PET CT imaging has the potential in diagnosing cardiac rejection. The investigators aim to recruit 20 heart transplant subjects within two groups of 10 ...
Detailed Description
Approximately 12% of heart transplant recipients are treated for cardiac rejection during their first year of follow-up. Rejection is the cause of death in 8-10% of cases in the first three years. Cur...
Eligibility Criteria
Inclusion
- All heart transplant recipients with definite cardiac rejection or definite no rejection with evidence of no significant coronary disease within the last 12 months (e.g with any of the following tests (1)angiogram (2) CTCA (3) MPS (4) CMR (5) other coronary ischaemia test)
Exclusion
- Unable to have a PET CT scan or comply with the dietary protocol
- Age less than 18 years old
- Unable to consent
- Presence of significant coronary disease or coronary ischaemia
- Insulin dependent diabetics
- Pregnant or breast feeding individuals
Key Trial Info
Start Date :
September 30 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 2 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06519240
Start Date
September 30 2024
End Date
October 2 2026
Last Update
July 25 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.